Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT04132960
Brief Summary:
Multicenter, open-label phase II trial assessing the efficacy of DS-8201a monotherapy in patients with metastatic breast cancer.
Detailed Description:
The main objective is to evaluate the anti-tumor activity of DS-8201a in three cohorts of advanced breast cancer patients:
* Cohort 1: HER2 over-expressing (HER2 IHC3+ or HER2 IHC2+/ISH+)
* Cohort 2: HER2 low-expressing (IHC1+ or IHC2+/ISH-)
* Cohort 3: HER2 non-expressing (IHC0+)
Study:
NCT04132960
Study Brief:
Protocol Section:
NCT04132960